Contact details
Professor Michael D Schneider
Chair in Cardiology
National Heart & Lung Institute
258
Sir Alexander Fleming Building
South Kensington Campus
Tel: +44 (0)20 7594 3027
Email:
Professor Michael D Schneider
Professor Schneider was recruited in September 2007 as the incoming Head of Cardiovascular Science for the National Heart and Lung Institute, and and served as Head of NHLI from 1 January 2009 through 31 August 2011.
He was educated at Harvard, the University of Pennsylvania, and Duke, followed by research training at the NIH under Nobel Laureate Marshall Nirenberg.
In 1984, he was appointed to the nascent program in cardiac molecular biology at Baylor College of Medicine, ultimately becoming Professor of Medicine, Molecular & Cellular Biology, and Molecular Physiology & Biophysics, Director of the Center for Cardiovascular Development, and inaugural recipient of the M. D. Anderson Foundation Chair. His trainees number more than 60, and have been recognized by young investigator competitions world-wide.
Professor Schneider is the British Heart Foundation Simon Marks Professor of Regenerative Cardiology and Director of Imperial's BHF Centre for Research Excellence. He is the recipient of a Royal Society Wolfson Research Merit Award, an ERC Advanced Investigator Grant, the 2007 Distinguished Achievement Award of the American Heart Association Council on Basic Cardiovascular Sciences, and the 2008 Medical Futures Cardiovascular Innovation Award. He currently serves as a member of the MRC Council.
Professor Schneider heads the Cardiac Myogenesis, Death and Regeneration research group and leads Imperial's MRC-BHF Cardiovascular Stem Cell Research Strategic Development Grant, an auspicious collaboration between the NHLI and the MRC Clinical Sciences Centre.
Selected Publications
Journals
- Liu Y; Asakura M; Inoue H; Nakamura T; Sano M; Niu Z; Chen M; Schwartz RJ; et alSchneider MD. (6 Mar 2007). Sox17 is essential for the specification of cardiac mesoderm in embryonic stem cells. Proc Natl Acad Sci U S A. 104:3859-3864. DOI.
- Sano M; Izumi Y; Helenius K; Asakura M; Rossi DJ; Xie M; Taffet G; Hu L; et alPautler RG; Wilson CR; Boudina S; Abel ED; Taegtmeyer H; Scaglia F; Graham BH; Kralli A; Shimizu N; Tanaka H; Mäkelä TP; Schneider MD. (Feb 2007). Ménage-à-trois 1 is critical for the transcriptional function of PPARgamma coactivator 1. Cell Metab. 5:129-142. DOI.
- Xie M; Zhang D; Dyck JR; Li Y; Zhang H; Morishima M; Mann DL; Taffet GE; et alBaldini A; Khoury DS; Schneider MD. (14 Nov 2006). A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci U S A. 103:17378-17383. DOI.
- Sano M; Wang SC; Shirai M; Scaglia F; Xie M; Sakai S; Tanaka T; Kulkarni PA; et alBarger PM; Youker KA; Taffet GE; Hamamori Y; Michael LH; Craigen WJ; Schneider MD. (1 Sep 2004). Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure. EMBO J. 23:3559-3569. DOI.
- Oh H; Bradfute SB; Gallardo TD; Nakamura T; Gaussin V; Mishina Y; Pocius J; Michael LH; et alBehringer RR; Garry DJ; Entman ML; Schneider MD. (14 Oct 2003). Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A. 100:12313-12318. DOI.
- Nakamura T; Sano M; Songyang Z; Schneider MD. (13 May 2003). A Wnt- and beta -catenin-dependent pathway for mammalian cardiac myogenesis. Proc Natl Acad Sci U S A. 100:5834-5839. DOI.
